Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial
Queen Mary University of London · Barts Health NHS Trust · +21 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
69
total citations
- FWCI
- 105.92
- Percentile
- 100%
- References
- 35
Citations per year
Authors
21Topics & keywords
Topics
Keywords
- Medicine
- Urothelial carcinoma
- Tropics
- Oncology
- Metastatic Urothelial Carcinoma
- Randomized controlled trial
- Urothelial cancer
- Internal medicine
No related works found for this paper.